A common diabetes drug may help slow age-related vision loss, giving researchers a promising new clue for protecting eyesight ...
South Africa's Aspen Pharmacare said on Monday that its Canadian subsidiary had received regulatory approval from Health ...
An international study found that finerenone slows kidney function decline and reduces the risk of serious kidney and ...
Health insurance covers the high costs of diabetes, such as a hospital stay for a serious complication, but not the daily costs of medicines and tests.
As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, ...
PvPI urges public for timely reporting of ADRs to strengthen safety monitoring of diabetes drug semaglutide: Shardul Nautiyal, Mumbai Monday, July 20, 2026, 08:00 Hrs [IST] Recogn ...
Beth Motley, a primary care physician specializing in family and lifestyle medicine, knows sharing a difficult journey can make all the difference ...
Boehringer Ingelheim’s top-selling drug lifted sales in the first half, as the German drugmaker gears up to file for U.S.
A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...
Morning Overview on MSN
Regular acetaminophen may raise stroke risk for older adults with diabetes
Older adults with diabetes who take acetaminophen on a regular basis may face a stroke risk roughly three times higher than ...
Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month, partnering with healthcare company Acino to expand patient access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results